Pontifax Management 4 G.P. (2015) Ltd. (CIK 0001726334)

Latest company ownership

Role: 10% Owner
Shares held
884,671
Last filed at
Nov 13, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
411,681
Last filed at
Sep 16, 2025
Confidence Score
59.4
2025Q4
Confidence Score History
2025Q3 2025Q4
Shares held
10,500
Last filed at
Oct 17, 2025
Confidence Score
23.8
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 15, 2025 Oct 17, 2025 Keros Therapeutics, Inc. 10% Owner Sell 15.0 -4,787,331 -99.78% $85M
Sep 12, 2025 Sep 16, 2025 LB PHARMACEUTICALS INC 10% Owner Buy 100.0 +1,000,000 242.91% $15M
Nov 17, 2020 Nov 19, 2020 Keros Therapeutics, Inc. 10% Owner Buy 87.5 +60,000 1.27% $3M
Apr 13, 2020 Apr 13, 2020 Keros Therapeutics, Inc. 10% Owner Buy 100.0 +437,499 10.18% $7M
Nov 11, 2019 Nov 13, 2019 89bio, Inc. 10% Owner Buy 100.0 +250,000 100.00% $4M